openPR Logo
Press release

Spasticity Treatment Market : Startup Strategy Resources, Grow Pricing Activity and Forecasts to 2025

07-11-2017 04:54 PM CET | Health & Medicine

Press release from: Transparency Market Research

Spasticity Treatment Market : Startup Strategy Resources, Grow

Spasticity is a medical condition where muscles get continuously contracted. Muscle contraction leads to muscle stiffness and tightening, affecting normal muscle movement in individuals affected with spasticity. Injury to the part of the brain or spinal cord which controls voluntary movement of the muscles can cause spasticity. The damage triggers a change in balance of neural signaling between the central nervous system and the muscles. 

View Report @ http://www.transparencymarketresearch.com/spasticity-treatment-market.html

Spasticity can occur due to various medical conditions such as cerebral palsy, multiple sclerosis, and traumatic brain injury. According to the American Association of Neurological Surgeons, there are approximately 12 million people affected by spasticity in the world; of these nearly 80% of the individuals affected by spasticity have spasticity. In the U.S., nearly 500,000 people have cerebral palsy; of these 400,000 have cerebral palsy associated spasticity. An estimated 400,000 individuals are affected by multiple sclerosis in the U.S. and around 320,000 individuals with multiple sclerosis disorder have spasticity. 

Spasticity can occur due to numerous other conditions such as injury to the spinal cord, brain damage due to lack of oxygen, encephalitis, meningitis, phenylketonuria, Lou Gehrig's disease, and adrenoleukodystrophy. Spasticity symptoms include muscle tightening and uncontrollable spasm mostly in legs and arms. It can also lead to joint pain and lower back pain. In adverse conditions, spasticity can cause restricted movement, extreme muscle contractions, affect protein synthesis in muscle, urinary tract infection, chronic constipation, pressure sores, and inhibit longitudinal muscle growth. 

Various treatments are available for spasticity based on cause, age of patient, and spasticity severity. Physical therapy is used to maintain or improve muscle mobility, increase strength and muscle coordination, use of braces, and electrical stimulation. Other spasticity treatments include oral medications and in some cases neuro-surgical procedures such as intrathecal baclofen (ITB) pumps and selective dorsal rhizotomy (SDR). On June 06, 2017, Ipsen announced the U.S. Food and Drug Administration (FDA) approval for expanded use of Dysport (abobotulinumtoxinA) injection for treating spasticity in adults with lower limb spasticity. In July 2016, the medication had received approval to treat pediatric patients with lower limb spasticity and in July 2015, the medication was approved for the treatment of upper limb spasticity in adults. 

Oral medication for treatment of spasticity is generally considered when spasticity symptoms become adverse and start affecting daily muscle functioning in an individual. Spasticity medication is used in combination of one or more drugs. Spasticity oral medication comprises the use of benzodiazepines, imidazole, and gamma-amino butyric acid analogs. 

Increasing awareness, growing research, changing lifestyle, advancements in the health care industry, launch of novel therapeutics, and rising per capita income in emerging markets are expected to drive the spasticity treatment market during the forecast period. However, lack of disease awareness in emerging economies, overall high cost of treatment, stringent government regulations, and unfavorable reimbursement are likely to restrain the market. 

Get accurate market forecast and analysis on the Spasticity Treatment Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=27014

Geographically, the global spasticity treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global spasticity treatment market due of increasing population, rising geriatric population, increasing number of screening procedures, presence of leading manufacturers, and technological advancements. North America is closely followed by Europe and Asia Pacific. Asia Pacific is an emerging market for spasticity treatment because of increasing health care expenditure, rising population, and growing awareness. 

Key players in the global spasticity treatment market are Codman & Shurtleff, Inc., Medtronic, Inc., InMed Pharmaceuticals, Inc., Ipsen, Orient Pharma Co., Ltd., Taj Pharmaceuticals Limited, MediciNova, Inc., Sanofi, and Genentech, Inc., among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Spasticity Treatment Market : Startup Strategy Resources, Grow Pricing Activity and Forecasts to 2025 here

News-ID: 619737 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Spasticity

Paediatric Spasticity Treatment Market Future Demands, Regional Developments and …
The paediatric spasticity treatment market is expected to register a CAGR of 10% during the forecast period. Paediatric Spasticity results due to damage of portion of brain or spinal cord which controls the voluntary movement. When paediatric spasticity occurs due to injury or disease, nerve signals do not reach muscles and continuously contract which causes stiffness and tightness which interfere with movement and speech. Several drugs are available to treat
Paediatric Spasticity Treatment Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Paediatric Spasticity Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Paediatric Spasticity Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Paediatric Spasticity Treatment Market  2019: Size, Business Growth, Technolog …
Paediatric Spasticity Treatment: Market Insights Pediatric Spasticity results due to damage of portion of brain or spinal cord which controls the voluntary movement. When pediatric spasticity occurs due to injury or disease, nerve signals do not reach muscles and continuously contract which causes stiffness and tightness which interfere with movement and speech. Several drugs are available to treat the Pediatric Spasticity, drugs are injected into the affected nerve or the muscle.
Global Muscle Spasticity Market 2018 Size, Trends, Industry Analysis, Leading Pl …
Muscle Spasticity Market: WiseGuyReports.com adds “Muscle Spasticity Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2027” reports tits database. Executive Summary “Muscle Spasticity - Market Insights, Epidemiology and Market Forecast – 2027” report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current
Spasticity Treatment Market Size To Expand Significantly By The End Of 2025
Spasticity is a medical condition where muscles get continuously contracted. Muscle contraction leads to muscle stiffness and tightening, affecting normal muscle movement in individuals affected with spasticity. Injury to the part of the brain or spinal cord which controls voluntary movement of the muscles can cause spasticity. The damage triggers a change in balance of neural signaling between the central nervous system and the muscles. Spasticity can occur due to various
Spasticity Treatment Market | Codman & Shurtleff, Medtronic, Sanofi, InMed Pharm …
HTF MI published a new industry research that focuses on Spasticity Treatment market and delivers in-depth market analysis and future prospects of Global Spasticity Treatment market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. The study is